究極の株式投資（究株）の掲示板

>>21966

AN FRANCISCO, July 14 (Xinhua) -- A genome sequencing test developed at the University of California, San Francisco, that can rapidly pinpoint the cause of a bacterial, viral, fungal or parasitic infection from among a huge range of possibilities is now available across the United States.

The next-gen precision diagnostics is expected to help physicians diagnose mysterious cases of neurological infection in acutely ill patients.

Researchers at UCSF have used the test on a trial basis to diagnose a number of patients, including the well-known case of a 14-year-old boy who was near death with swelling in his brain. The boy had undergone months of unsuccessful attempts to identify the cause of his illness with conventional lab tests, expensive imaging technologies, and invasive procedures, including a brain biopsy.